Int. Journal of Clinical Pharmacology and Therapeutics, Volume 53 - May (356 - 362)

Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections
Taotao Wang1, Na Li1, Sasa Hu1, Jiao Xie1, Jin’e Lei2, Yan Wang1, Xiaowei Zheng1, Jianfeng Xing3, Yalin Dong1
1 Department of Pharmacy, 2 Department of Laboratory, The First Affiliated Hospital of Medical College, and 3 School of Pharmacy, Xi’an Jiaotong University, Xi’an, China

Add to Cart  

 

DOI 10.5414/CP202247

Abstract

Objective: The objective of this study was to identify the factors influencing trough teicoplanin concentrations (Cmin), to investigate the relationship between teicoplanin Cmin with efficacy and safety, and to determine a target therapeutic concentration. Methods: An analysis was performed on 95 serum concentrations from 50 patients with gram-positive infections who received teicoplanin treatment. Teicoplanin serum concentrations were measured by high-performance liquid chromatography. Univariate and multivariable analysis were performed to investigate the effect of independent variables on teicoplanin Cmin. A logistic regression analysis was used to determine the relationship between teicoplanin Cmin and efficacy and safety. Results: Teicoplanin therapy was effective in 74.0% (37/50) of patients, and 10.0% (5/50) of patients exhibited signs of adverse events. Using multivariable linear regression, two covariates were found to be a significant effect on teicoplanin Cmin: dosage (mg/kg), and creatinine clearance rate (CLcr). There was no covariate that has a significant impact on the safety of teicoplanin and only teicoplanin Cmin has a significant impact on the efficacy of treatment in the logistics regression. The logistics regression analysis showed that teicoplanin Cmin of 10 mg/L was associated with a 79.4% probability of success response. Conclusions: This study highlighted that teicoplanin Cmin was strongly influenced by the values of dosage (mg/kg) and CLcr and the teicoplanin Cmin range of 10 – 20 mg/L was identified as the therapeutic target with optimum clinical efficacy and safety.

Author Details

Authors

Departments

  • 1 Department of Pharmacy,
  • 2 Department of Laboratory, The First Affiliated Hospital of Medical College, and
  • 3 School of Pharmacy, Xi’an Jiaotong University, Xi’an, China

Address

Yalin Dong, PhD
Department of Pharmacy
The First Affiliated Hospital of Medical College
Xi’an Jiaotong University, Xi’an 710061, China
Email: [email protected].

Citation

Taotao Wang, Na Li, Sasa Hu, Jiao Xie, Jin’e Lei, Yan Wang, Xiaowei Zheng, Jianfeng Xing, and Yalin Dong.Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections. 2015; 53: 356-362. doi: 10.5414/CP202247.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart